Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - Pharmaceutical News - Intrinsic Imaging Awarded Pivotal Phase II Clinical Trial Focused on Treatment of Degenerative Neuromuscular Disorder [Sudan Tribune] - September 19, 2017

Pharmacy News Article

 9/13/17 - Intrinsic Imaging Awarded Pivotal Phase II Clinical Trial Focused on Treatment of Degenerative Neuromuscular Disorder [Sudan Tribune]

Intrinsic Imaging, a full-service medical imaging core lab providing comprehensive services in support of Phase I-IV clinical trials and Class I, II, III medical device trials, announces today the award of a Phase II clinical trial for the evaluation of a novel biologic for the treatment of a rare degenerative neuromuscular disorder.

Intrinsic Imaging will provide its full suite of imaging core lab services for the duration of this trial. These services include study management, protocol and charter development, site qualification, training and management, image transfer, quality control and processing. Intrinsic Imaging will also perform all radiological reviews.

Intrinsic Imagings team has extensive experience in providing services in support of Phase I-IV clinical trials and medical device trials involving musculoskeletal imaging. With its team of 10 full-time board-certified, fellowship-trained musculoskeletal radiologists, their expertise includes the full complement of joint and spine disease processes and musculoskeletal interventions including pain management and device. Their multiple modality expertise in musculoskeletal imaging includes, but is not limited to, ultrasound, nuclear imaging, DXA, MR, and CT including novel techniques such as QCT, T2 Cartilage imaging, MARS imaging and Kinetic MRI.

Intrinsic Imaging was selected for this pivotal study due to our teams expertise and operational excellence in conducting musculoskeletal clinical trials, said Todd Joron, President and COO at Intrinsic Imaging. We are excited to provide our expertise in the evaluation of this novel biologic and to help our partner further the development of their life altering treatment.

This trial will be conducted within Intrinsic Imagings quality framework. With its portfolio of five ISO certifications, Intrinsic Imaging has the most comprehensive and most sophisticated quality management system in the industry.



(c) 2003-2017 SudanTribune - All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 19: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Last Chance
Sep 20: What's New? New Treatments for Type 2 Diabetes
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415